385 related articles for article (PubMed ID: 36525603)
1. New perspectives on ferroptosis and its role in hepatocellular carcinoma.
Cong T; Luo Y; Fu Y; Liu Y; Li Y; Li X
Chin Med J (Engl); 2022 Sep; 135(18):2157-2166. PubMed ID: 36525603
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and regulations of ferroptosis.
Zhang XD; Liu ZY; Wang MS; Guo YX; Wang XK; Luo K; Huang S; Li RF
Front Immunol; 2023; 14():1269451. PubMed ID: 37868994
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis: Final destination for cancer?
Ye Z; Liu W; Zhuo Q; Hu Q; Liu M; Sun Q; Zhang Z; Fan G; Xu W; Ji S; Yu X; Qin Y; Xu X
Cell Prolif; 2020 Mar; 53(3):e12761. PubMed ID: 32100402
[TBL] [Abstract][Full Text] [Related]
4. Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis.
Chen M; Shi Z; Sun Y; Ning H; Gu X; Zhang L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675129
[TBL] [Abstract][Full Text] [Related]
5. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
6. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.
Du Y; Zhou Y; Yan X; Pan F; He L; Guo Z; Hu Z
Cell Death Differ; 2024 Apr; 31(4):431-446. PubMed ID: 38418695
[TBL] [Abstract][Full Text] [Related]
7. DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma.
Li Q; Yuan H; Zhao G; Ou D; Zhang J; Li L; Li S; Feng T; Gu R; Kou Q; Wang Q; Li S; Wang G; Zhao M; Yu H; Qu J; Lin P; Li K
Biochem Pharmacol; 2024 Jul; 225():116251. PubMed ID: 38701867
[TBL] [Abstract][Full Text] [Related]
8. The mechanism and progress of ferroptosis in pancreatic cancer.
Bao ZH; Hou XB; Li HL; Mao YF; Wang WR
Acta Histochem; 2022 Aug; 124(6):151919. PubMed ID: 35772355
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of ferroptosis and its effects on bladder cancer.
Li R; Ning Y; Yuan Y; Yang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):286-295. PubMed ID: 38755725
[TBL] [Abstract][Full Text] [Related]
10. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
Lee J; Roh JL
Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
[TBL] [Abstract][Full Text] [Related]
11. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
12. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis.
Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
Cell Biol Int; 2020 Nov; 44(11):2344-2356. PubMed ID: 32808701
[TBL] [Abstract][Full Text] [Related]
13. Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease.
Lin KJ; Chen SD; Lin KL; Liou CW; Lan MY; Chuang YC; Wang PW; Lee JJ; Wang FS; Lin HY; Lin TK
Cells; 2022 Nov; 11(23):. PubMed ID: 36497089
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
[No Abstract] [Full Text] [Related]
15. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
[TBL] [Abstract][Full Text] [Related]
16. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
[TBL] [Abstract][Full Text] [Related]
17. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells.
Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W
Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528
[TBL] [Abstract][Full Text] [Related]
18. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis Inducers for Prostate Cancer Therapy.
Zaffaroni N; Beretta GL
Curr Med Chem; 2022; 29(24):4185-4201. PubMed ID: 35021966
[TBL] [Abstract][Full Text] [Related]
20. Rhamnazin Inhibits Hepatocellular Carcinoma Cell Aggressiveness in Vitro via Glutathione Peroxidase 4-Dependent Ferroptosis.
Mei F; Liu Y; Zheng S
Tohoku J Exp Med; 2022 Sep; 258(2):111-120. PubMed ID: 35896364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
